To our business partners in the delivery of pharmaceutical health care:
We continue to monitor the development of the COVID-19/Coronavirus situation as it relates to our operations. Our leadership team is in close communication and continues to adjust to meet the needs of our customers.
As your pharmacy partner, we are dedicated to providing all necessary support enabling you to provide high-quality health care across the globe. With that said, we have taken the following steps to ensure our continuity of operations:
- We are working with our vendor partners to understand if there are any limitations or delivery concerns for any products required to meet our obligations for our current business partners. To this point, no concerns have been identified.
- Our organization continues to work in our office in Johnson City, NY, and we are taking the precautions recommended by the CDC. We will monitor this situation daily and determine if any modifications to this policy are required.
- At this point, we are limiting travel to direct support of customers with highest priority to active pharmacies. We will be watching this closely to see if the recommendations change, but currently, there are no CDC recommended restrictions for domestic air travel. This currently allows us to dispatch the site staff required to respond to customer needs. However, if your location has specific restrictions which would prohibit our personnel from housing or sustenance we will access those on a case-by-case basis.
- We are also looking at our customer base and making sure that all customers can be supported on-site by one of our field staff and what could occur with various travel restriction scenarios.
Innovation will continue operations in production and support of all our customers. If there is a change in CDC or WHO guidelines, we will adjust specific business level operations to respond to immediate customer needs. We are here for you as you provide critical pharmaceutical care across the globe. We believe we are a critical component of how our nation is responding to this crisis and we will rise to the challenge. We are your partner and we appreciate your dedication to your mission of providing leading edge pharmaceutical care to your entire patient/customer base.
Marvin Richardson, Co-President